INOTEK PHARMACEUTICALS CORP's ticker is and the CUSIP is 45780V902. A total of 3 filers reported holding INOTEK PHARMACEUTICALS CORP in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $4,000 | +33.3% | 65 | -5.8% | 0.00% | – |
| Q3 2017 | $3,000 | 0.0% | 69 | -68.6% | 0.00% | – |
| Q2 2017 | $3,000 | +200.0% | 220 | +94.7% | 0.00% | – |
| Q1 2017 | $1,000 | -91.7% | 113 | +135.4% | 0.00% | -100.0% |
| Q4 2016 | $12,000 | +500.0% | 48 | -4.0% | 0.00% | – |
| Q3 2016 | $2,000 | +100.0% | 50 | +316.7% | 0.00% | – |
| Q2 2016 | $1,000 | – | 12 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 12 | -77.8% | 0.00% | – |
| Q4 2015 | $3,000 | – | 54 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 106 | $100,000 | 0.00% |
| SIMPLEX TRADING, LLC | 50 | $2,000 | 0.00% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 124 | $5,000 | 0.00% |